JAG2 and breast cancer: IHC in breast cancer patient samples revealed the upregulation of NICD1 and Jag2 in the invasive front rather than within the core of the tumor, suggesting Jag2 mediated Notch1 activation playing a role in breast cancer invasion and metastasis.